Skin exposure can cause irritation, contact dermatitis, or allergic reactions, especially with plant extracts and adhesives, and manufacturing quality varies widely across wellness products
Tirzepatide , a dual GLP-1/GIP receptor agonist, has been approved by NICE for type 2 diabetes management
TRICARE covers certain GLP-1 medications for qualifying beneficiaries
This graduated approach minimizes side effects while progressively increasing therapeutic benefit
GLP-1 medications are typically prescribed for individuals who have a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have at least one weight-related health condition, such as type 2 diabetes or high blood pressure
Unlike conventional weight-loss medications, retatrutide works on three metabolic hormone receptors simultaneously, offering a more comprehensive approach to obesity, metabolic disease, and fat redistribution concerns that are increasingly prevalent in urban Indian populations